7 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 16.3% per year over the past 5 years.
Operating margin has expanded, at 1.9% in the latest year.
Free cash flow has declined 0.2% per year over the past 5 years.
Financial health
Operating income covered interest expense 1.8× in the latest year.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$13.2B
$36M
0.0%
1.9%
$110M
—
$854M
2024
$11.7B
$138M
0.0%
1.9%
$190M
—
$413M
2023
$9.8B
$233M
0.0%
3.3%
$284M
—
$468M
2022
$9.0B
$200M
0.0%
2.7%
$200M
$1.7B
$495M
2021
$7.9B
$161M
0.0%
1.9%
$205M
—
$333M
2020
$6.2B
-$31M
0.0%
0.3%
$111M
—
$328M
2019
$6.1B
$60M
0.0%
2.5%
-$77M
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$3.3B
$4M
0.0%
1.2%
-$34M
—
$794M
Dec '25
$3.5B
$43M
0.0%
2.7%
$115M
—
$854M
Sep '25
$3.4B
$59M
0.0%
3.5%
$88M
—
$339M
Jun '25
$3.3B
$26M
0.0%
2.7%
-$44M
—
$205M
Mar '25
$3.0B
-$96M
0.0%
-1.9%
-$49M
—
$288M
Dec '24
$3.3B
$100M
0.0%
3.1%
$82M
—
$413M
Sep '24
$3.2B
$33M
0.0%
2.6%
$104M
—
$548M
Jun '24
$2.8B
$38M
0.0%
2.6%
$27M
—
$469M
Mar '24
$2.5B
-$37M
0.0%
-1.6%
-$23M
—
$423M
Dec '23
$2.6B
$73M
0.0%
3.4%
$146M
—
$468M
Sep '23
$2.5B
$66M
0.0%
3.6%
$188M
—
$473M
Jun '23
$2.4B
$65M
0.0%
4.1%
$2M
$1.6B
$305M
Mar '23
$2.3B
$25M
0.0%
1.8%
-$52M
$1.7B
$426M
Dec '22
$2.5B
$46M
0.0%
3.0%
$123M
$1.7B
$495M
Sep '22
$2.3B
$63M
0.0%
3.1%
$31M
—
$434M
Jun '22
$2.2B
$51M
0.0%
2.7%
$65M
—
$384M
Mar '22
$2.1B
$37M
0.0%
1.8%
-$19M
—
$312M
Dec '21
$2.3B
$56M
0.0%
2.8%
$134M
—
$333M
Sep '21
$2.0B
$72M
0.0%
1.8%
$44M
—
$275M
Jun '21
$1.9B
$11M
0.0%
1.2%
$47M
—
$326M
Valuation over time
How the market has priced GXO against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 29.0× (Mar '23) to 162.8× (Jun '26).
The price-to-sales ratio has fallen from 0.6× (Mar '23) to 0.4× (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is GXO growing its revenue and profit?
Over the past 5 years, Gxo Logistics, Inc.'s revenue has grown 16.3% per year. These are computed facts, not advice.
How much debt does GXO have?
As of FY2025, Gxo Logistics, Inc. reported — of total debt against $854M of cash; operating income covered interest expense 1.8×.
What is GXO's profit margin?
In FY2025, gross margin was —, operating margin 1.9%, and net margin 0.3%.
What is GXO's P/E ratio?
As of Jun '26, Gxo Logistics, Inc. traded at a price-to-earnings ratio of about 162.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.